Literature DB >> 23150551

A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.

Jason M Link1, Sara Ota, Zi-Qiang Zhou, Colin J Daniel, Rosalie C Sears, Peter J Hurlin.   

Abstract

Mnt (Max's next tango) is a Max-interacting transcriptional repressor that can antagonize both the proproliferative and proapoptotic functions of Myc in vitro. To ascertain the physiologically relevant functions of Mnt and to help define the relationship between Mnt and Myc in vivo, we generated a series of mouse strains in which Mnt was deleted in T cells in the absence of endogenous c-Myc or in the presence of ectopic c-Myc. We found that apoptosis caused by loss of Mnt did not require Myc but that ectopic Myc expression dramatically decreased the survival of both Mnt-deficient T cells in vivo and Mnt-deficient MEFs in vitro. Consequently, Myc-driven proliferative expansion of T cells in vitro and thymoma formation in vivo were prevented by the absence of Mnt. Consistent with T-cell models, mouse embryo fibroblasts (MEFs) lacking Mnt were refractory to oncogenic transformation by Myc. Tumor suppression caused by loss of Mnt was linked to increased apoptosis mediated by reactive oxygen species (ROS). Thus, although theoretically and experimentally a Myc antagonist, the dominant physiological role of Mnt appears to be suppression of apoptosis. Our results redefine the physiological relationship between Mnt and Myc and requirements for Myc-driven oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23150551      PMCID: PMC3511755          DOI: 10.1073/pnas.1206406109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

Authors:  Shala Dezfouli; Antony Bakke; Jie Huang; Anthony Wynshaw-Boris; Peter J Hurlin
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 2.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Authors:  Thomas W Kensler; Nobunao Wakabayashi; Shyam Biswal
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Revving the engine: signal transduction fuels T cell activation.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 4.  Of Myc and Mnt.

Authors:  C William Hooker; Peter J Hurlin
Journal:  J Cell Sci       Date:  2006-01-15       Impact factor: 5.285

Review 5.  Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

Authors:  Constadina Arvanitis; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2006-07-21       Impact factor: 15.707

6.  c-Myc mediates pre-TCR-induced proliferation but not developmental progression.

Authors:  Marei Dose; Irum Khan; Zhuyan Guo; Damian Kovalovsky; Andreas Krueger; Harald von Boehmer; Khashayarsha Khazaie; Fotini Gounari
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

7.  Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species.

Authors:  Yongqiang Chen; Eileen McMillan-Ward; Jiming Kong; Sara J Israels; Spencer B Gibson
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

8.  HIF-dependent antitumorigenic effect of antioxidants in vivo.

Authors:  Ping Gao; Huafeng Zhang; Ramani Dinavahi; Feng Li; Yan Xiang; Venu Raman; Zaver M Bhujwalla; Dean W Felsher; Linzhao Cheng; Jonathan Pevsner; Linda A Lee; Gregg L Semenza; Chi V Dang
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

Review 9.  Myc's broad reach.

Authors:  Martin Eilers; Robert N Eisenman
Journal:  Genes Dev       Date:  2008-10-15       Impact factor: 11.361

10.  Drosophila growth and development in the absence of dMyc and dMnt.

Authors:  Sarah B Pierce; Cynthia Yost; Sarah A R Anderson; Erin M Flynn; Jeffrey Delrow; Robert N Eisenman
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

View more
  22 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  Control of vertebrate development by MYC.

Authors:  Peter J Hurlin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 3.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

4.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.

Authors:  Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman
Journal:  Cancer Cell       Date:  2015-01-29       Impact factor: 31.743

5.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

6.  MYC needs MNT to drive B cells over the edge.

Authors:  Siegfried Janz
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

7.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

8.  The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Authors:  M Carmen Lafita-Navarro; Judit Liaño-Pons; Andrea Quintanilla; Ignacio Varela; Rosa Blanco; Fabiana Ourique; Gabriel Bretones; Julia Aresti; Ester Molina; Patrick Carroll; Peter Hurlin; Octavio A Romero; Montse Sanchez-Céspedes; Robert N Eisenman; M Dolores Delgado; Javier León
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

9.  MYC needs MNT.

Authors:  Jason M Link; Peter J Hurlin
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

10.  A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injury.

Authors:  Takehiko Takayanagi; Akito Eguchi; Akira Takaguri; Akinari Hinoki; Allison M Bourne; Katherine J Elliott; Peter J Hurlin; Satoru Eguchi
Journal:  Atherosclerosis       Date:  2013-03-13       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.